CHERINGTON CHARLES purchased 22.7% of their position (3.77M shares) of ERNEXA THERAPEUTICS INC. on the open market
Open‑market purchase worth $394.2K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/4/2025ACC: 0001104659-25-032060
Director10% Owner
Since Mar 2021
+3.77M
Net shares
Net buyer
$394.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.77M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.77M
Price / share
$0.10
Trade value
$394.17K
% of position
22.7%
4/2/2025
16.63M→20.40M
Total
Net shares
+3.77M
Net value
$394.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2025 | P · Purchase | +3.77M | $0.10 | $394.17K | 22.7% | 16.63M | 20.40M |
| Total | +3.77M | $394.17K | ||||||
Derivative Transactions0
No derivative transactions reported